Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery
Author Information
Author(s): Jocelyn T. De Yao, Sun Danyu, Powell Angela T., Rehmus Esther H.
Primary Institution: Akron General Medical Center
Hypothesis
Can bevacizumab and radiotherapy induce remission in patients with angiosarcoma who are not surgical candidates?
Conclusion
An 88-year-old patient with extensive scalp angiosarcoma achieved biopsy-proven remission with bevacizumab and radiotherapy without surgery.
Supporting Evidence
- Angiosarcoma is a rare and aggressive cancer with poor prognosis.
- Patients with extensive angiosarcoma often have limited treatment options.
- Bevacizumab has been used in conjunction with radiation therapy for angiosarcoma.
Takeaway
A very sick old man with a rare skin cancer got better after taking a medicine and getting radiation, even though he couldn't have surgery.
Methodology
The patient received bevacizumab and radiation therapy over a period of time without surgical intervention.
Potential Biases
Potential bias due to the lack of a control group and reliance on a single patient's outcome.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
An 88-year-old Caucasian male with a history of multiple comorbidities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website